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Abstract
Purpose Cyst infections are a common complication in autosomal dominant polycystic kidney disease (ADPKD). Diagnosing 
these infections often remains challenging. Conventional imaging techniques such as ultrasonography, computed tomography 
(CT), and standard magnetic resonance imaging have several drawbacks and disadvantages. The purpose of this pictorial 
essay was to illustrate and discuss the potential value of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-
PET)/CT in diagnosing cyst infection in ADPKD.
Methods Exemplary (ADPKD) patients who underwent FDG-PET/CT as part of their routine clinical work-up in our insti-
tution are presented to show the potential value and drawbacks of this imaging technique in diagnosing cyst infection. In 
addition, the current literature and guidelines on this topic were reviewed.
Results FDG-PET/CT appears to be a sensitive method for the detection of cyst infection, but it is not infallible. Furthermore, 
FDG uptake in cysts and cyst-like lesions is not specific and clinical and radiological correlations are essential to improve 
specificity and minimize the risk of falsely discarding other diseases, in particular malignancy.
Conclusion FDG-PET/CT seems to be a useful imaging modality to diagnose cyst infections in ADPKD. However, its exact 
diagnostic value has not been established yet due to the lack of a reliable reference standard in previous studies on this topic.
Keywords ADPKD · FDG-PET/CT · Infection
Introduction
Autosomal dominant polycystic kidney disease 
(ADPKD)
ADPKD is the most common hereditary kidney disease 
that leads to end-stage renal disease [1]. Over the course 
of years, patients with ADPKD develop multiple cysts in 
their kidneys. Hepatic cysts are the most common extrarenal 
manifestation of ADPKD, which can be found in 80% of 
patients at the age of 30. While ADPKD is often asympto-
matic in childhood, progressive expansion of the cysts leads 
to end-stage renal disease between age 58 and age 80 on 
average, depending on the causative genetic mutation (PKD1 
or PDK2, respectively) [2].
The clinical symptoms of ADPKD are often directly 
related to the expansion of renal cysts. Patients usually pre-
sent with complaints of pain, hematuria, but gastrointestinal 
symptoms such as obstipation and weight loss can also occur 
[3]. Elevated blood pressure due to increased activity of the 
renin–angiotensin system is also common [4].
ADPKD is usually diagnosed according to the criteria 
of Ravine [5], which are based on ultrasonographic imag-
ing and take into account the family history and age of the 
patient. Patients with a positive family history between the 
ages of 15 and 29 with more than two renal cysts in total, 
between 30 and 59 with two cysts in each kidney, or above 
60 with more than 4 cysts in each kidney are diagnosed as 
having ADPKD. Without a positive family history, ADPKD 
can be diagnosed if more than ten cysts are present in each 
kidney, regardless of age.
Besides hypertension, end-stage renal disease and pye-
lonephritis, cyst infection is a common complication of 
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ADPKD [6, 7]. Patients with a cyst infection usually present 
with symptoms such as flank pain and fever, mostly accom-
panied by an increased level of C-reactive protein (CRP) and 
leukocytosis. Because flank pain and fever are also common 
in cyst hemorrhage, pyelonephritis, and nephrolithiasis, fur-
ther diagnostic methods are necessary to settle the correct 
diagnosis [8].
Although cyst infection has a prevalence of up to one in 
two patients with ADPKD, diagnosis remains challenging 
[9]. The diagnostic reference is analysis of the cyst fluid, but 
cyst punctures can cause bleeding, rupture, and contamina-
tion of adjacent cysts and are therefore rarely performed 
[10].
The purpose of this pictorial essay was to illustrate and 
discuss the potential value of FDG-PET/CT compared to 
conventional imaging methods (ultrasonography, CT, and 
MRI) in diagnosing cyst infection in ADPKD.
Conventional imaging
Ultrasonography is often the initial step in locating the 
source of lower abdominal pain that is common in patients 
with cyst infections. It is relatively cheap compared to other 
cross-sectional imaging methods, does not use any poten-
tially harmful ionizing radiation, and also allows exclusion 
of hydronephrosis.
However, ultrasonography and other conventional radio-
logic modalities such as CT and standard magnetic reso-
nance imaging (MRI) are often of limited use in diagnos-
ing infection [11–13]. A diagnosis of infection with these 
modalities is mostly based on wall thickening and hetero-
geneous content of the cysts. However, since the presence 
and expansion of numerous cysts in polycystic disease often 
severely affects the normal anatomy of the affected organ, 
wall thickening can reflect residual functional parenchyma, 
and harmless intracystic cellular debris can also cause a het-
erogeneous cyst appearance. As a consequence, it is hard to 
distinguish between infected and non-infected cysts [13].
Besides these limitations, iodinated CT contrast 
agents and gadolinium-based MRI contrast agents can be 
Fig. 1  A 61-year-old man with ADPKD and unilateral renal agenesis 
was admitted to the hospital because of a possible urinary tract infec-
tion. He presented with complaints of cold shivers, pollakiuria, stran-
guria, lower abdominal pain and cloudy urine. Blood tests showed a 
CRP level of 363 mg/L and a white blood cell count of 6.6 × 109/L, 
while a urine culture tested positive for Escherichia coli. The 
patient’s clinical condition improved under ciprofloxacin treatment, 
but his CRP level remained high 5 days later at 154 mg/L. Because 
of the possibility of pyelonephritis or cyst infection, ultrasound was 
ordered. Ultrasonographic images of the liver (a) and kidney (b) 
showed multiple cysts, but no hydronephrosis and no potential site 
of infection. Subsequently, FDG-PET/CT was performed. Axial 
FDG-PET (c), low-dose CT (d), fused FDG-PET/CT (e), and coronal 
maximum intensity projection FDG-PET (f) showed pathologic FDG 
uptake of the wall of a cyst in the right kidney (arrows), consistent 
with cyst infection. No pathologic FDG-avid foci were detected else-
where. The patient was discharged 1 day after the FDG-PET/CT scan 
in good clinical condition, where he continued his course of cipro-
floxacin for 10 more days
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contraindicated in patients with impaired renal function (due 
to ADPKD) because of the potential risks of nephrotoxic-
ity and nephrogenic systemic fibrosis, respectively [13]. Of 
interest, diffusion-weighted MRI is a relatively new MRI 
technique that is sensitive to the random (Brownian) motion 
of water molecules, and can provide a high lesion-to-back-
ground contrast. Although it is particularly used in oncol-
ogy, it may also be used to diagnose (cyst) infections. A 
recent study showed a sensitivity and specificity around 80% 
for diagnosing cyst infection with combined MRI findings, 
which included high intracystic signal intensity on diffusion-
weighted imaging MRI and wall thickening. However, only 
patients with severe cyst infection were included, and the 
specificity dropped to 66% when patients had organomegaly, 
which is common in ADPKD [14]. Therefore, there is a need 
for alternative imaging methods for the evaluation of these 
patients.
FDG‑PET/CT
18F-fluoro-2-deoxy-d-glucose (FDG) positron emission 
tomography (PET) is considered a potentially useful imaging 
technique for detecting cyst infection. Activated inflamma-
tory and infectious cells (such as macrophages, lymphocytes 
and neutrophils) require a high amount of glucose and there-
fore also accumulate FDG [15]. The FDG accumulation can 
be visualized by PET with a high contrast-to-background 
ratio, and the concomitantly acquired low-dose CT can be 
used to anatomically pinpoint the sites of FDG accumulation 
and therefore sites of potential infection.
Various recent studies have investigated the diagnostic 
value of FDG-PET/CT in diagnosing cyst infections. For 
example, Sallée et al. [16] described 8 patients in whom a 
cyst infection was diagnosed based on FDG-PET/CT. Five 
patients had a definite cyst infection based on cyst aspira-
tion, and three patients a probable cyst infection based on the 
presence of all of the following five factors: fever, abdominal 
pain, increased CRP, the absence of cyst bleeding and the 
absence of any other possible cause of fever. In all 8 patients, 
FDG-PET/CT results were positive for infection (Figs. 1, 2, 
3, 4 and 5).    
Bobot et al. [10] described 32 cases of clinically sus-
pected cyst infections in 24 patients where FDG-PET/CT 
achieved a sensitivity of 77% and a specificity of 100% for 
diagnosing cyst infection. Three FDG-PET/CT positive 
cases were regarded as definitive cyst infection based on 
cyst aspiration, the other 11 FDG-PET/CT positive cases 
were considered as ‘likely cyst infections’ based on the five 
Fig. 2  A 53-year-old man with ADPKD presented at the emergency 
department because of abdominal pain, fever and a possible urinary 
tract infection. He had received a kidney transplant 1  month before 
because of end-stage renal disease. Blood tests showed a CRP level 
of 19 mg/L and a white blood cell count of 8.6 × 109/L, while a urine 
culture revealed Gram-negative rods. The patient was admitted, and 
an FDG-PET/CT scan was ordered to assess the native kidneys for 
infection. Coronal maximum intensity projection FDG-PET (a), low-
dose CT (b), and fused FDG-PET/CT (c) did not show any signs of 
(cyst) infection in the native kidneys, and no pathologic FDG-avid 
foci elsewhere. FDG-PET/CT findings provided confidence to the 
clinicians to attribute the clinical and laboratory findings to a simple 
cystitis. The patient was sent home in good clinical condition with a 
course of nitrofurantoin for 3 days
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criteria of Sallée et al. [16]. Long treatment with antibiotics 
before the FDG-PET/CT scan was suggested as the most 
likely explanation for false-negative cases.
Balbo et al. [17] described 32 cases of clinically sus-
pected cyst infections in 27 patients where FDG-PET/CT 
was reported to have a sensitivity of 95% and a specificity of 
100%. Among these, there were 24 episodes of cyst infection 
in 18 patients. Six cases were definite cyst infections based 
on cyst aspiration, the other 18 cases were ‘probably cyst 
infections’, also based on the criteria of Sallée et al. [16].
Finally, we recently analyzed 37 cases in 32 patients 
where FDG-PET/CT achieved a sensitivity of 86% and a 
specificity of 81%, with 18 true-positive and 11 true-nega-
tive cases (data not published yet). All cases were assessed 
based on the criteria of Sallée et al. [16], because no cyst 
punctures were performed.
Discussion
Cyst infections are often a diagnostic challenge, particularly 
in case of polycystic disease such as ADPKD. We reviewed 
the current evidence and provided exemplary cases to illus-
trate the potential benefits and pitfalls of FDG-PET/CT in 
diagnosing cyst infection.
In cases 1 and 3, the correct diagnosis of a cyst infection 
was based on a positive FDG-PET/CT scan, and in case 2 a 
suspected cyst infection was ruled out. In cases 1 and 3, the 
patients clinically improved on antibiotics able to penetrate 
cyst walls, and in case 2, the patient improved on a course of 
nitrofurantoin for cystitis. All patients were discharged from 
hospital in good clinical condition.
Case 4 illustrated that FDG-PET/CT can also result in a 
false positive diagnosis of a cyst infection in more compli-
cated cysts. Increased FDG uptake in complicated cyst-like 
structures is not specific for infection and can also reflect 
malignancy [18]. This was also shown in case 5, where a 
complicated cyst (Bosniak category 3–4) did not show mark-
edly increased FDG uptake, although pathologic testing later 
confirmed the presence of multiple infected cysts.
Fig. 3  A 68-year-old woman with ADPKD presented with a feel-
ing of general malaise that had been increasing over the course of 
2 weeks. Nocturnal sweats were also present in the last week. There 
was no fever or abdominal pain. Blood tests showed a CRP level of 
242 mg/L and a white blood cell count of 15.8 × 109/L. Blood cul-
tures were positive for Escherichia coli and urine cultures were 
positive for Klebsiella pneumoniae. The patient was admitted with 
a differential diagnosis of urosepsis or an infection of her abdomi-
nal aortic endograft. Despite intravenous treatment with cefuro-
xime for 4 days, infectious parameters remained high (CRP level of 
228 mg/L). To find the source of infection, a contrast enhanced CT 
scan of the abdomen was ordered. Axial arterial phase (a) and portal-
venous phase (b) full-dose CT scans showed multiple liver cysts that 
were otherwise unremarkable. Because CT failed to identify any site 
of infection, an FDG-PET/CT scan was ordered. Axial FDG-PET (c) 
fused FDG-PET/CT (d), and coronal maximum intensity projection 
FDG-PET (e) showed pathologic FDG uptake of the wall of a cyst in 
segment seven of the liver (arrows), in keeping with cyst infection. 
No pathologic FDG-avid foci were detected elsewhere. The antibiotic 
regimen was changed to ceftriaxone for better cyst penetration. CRP 
levels decreased to 49 mg/L in 4 days. The patient was sent home in 
good condition with a subsequent course of ciprofloxacin
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In the current guidelines for use of FDG-PET/CT in 
inflammation and infection, several diseases are marked as 
‘major indication’ based on sufficient evidence in literature 
of FDG-PET/CT’s high sensitivity and specificity in these 
diseases [19]. These include, for example, sarcoidosis, spinal 
infection, and vasculitides. Other useful applications that are 
mentioned, but are not a major indication yet due to insuf-
ficient evidence, include evaluation of suspected infection 
of intravascular devices and potentially infected hepatic and 
renal cysts in polycystic diseases.
These guidelines, however, were established in 2013 
based on 7 studies reporting in total only 34 scans in 28 
patients [20–26]. Since then, various larger studies were 
published, including in total more than a hundred cases and 
describing in all cases a high sensitivity and specificity for 
FDG-PET/CT in diagnosing cyst infection ([10, 17], own 
study (not published yet)). Therefore, it seems appropriate 
to reassess the guidelines and to state whether a suspected 
cyst infection in polycystic diseases should be considered 
a major indication for performing an FDG-PET/CT scan.
However, the main limitation of these recent studies 
[10, 16, 17] was the lack of a gold diagnostic standard to 
validate the results of the FDG-PET/CT scan. As men-
tioned previously, cyst puncture is currently the only true 
gold diagnostic standard, but it may lead to serious com-
plications and is therefore rarely performed. The majority 
of the cases that were considered as true positives were 
diagnosed based on the five clinical criteria from Sallée 
et al. [16]. Therefore, patients who missed one or more of 
the clinical criteria from Sallée et al. [16] but did show 
Fig. 4  A 71-year-old woman presented to the rheumatology and 
immunology department because of fatigue, general malaise and 
involuntary weight loss of 9 kg in 5 months. She did not have fever 
or abdominal pain. Blood tests showed a CRP level of 256  mg/L 
and a white blood cell count of 11.0  ×  109/L. An FDG-PET/CT 
scan was ordered to assess the possibility of vasculitis, infection, or 
malignancy. Axial FDG-PET (a), low-dose CT (b), and fused FDG-
PET/CT (c) showed an abnormal spleen (arrows) that was markedly 
enlarged with inhomogeneous areas of pathologic FDG uptake and 
central photopenic areas that could not be clearly assessed on the 
low-dose CT (b). Coronal FDG-PET (d), low-dose CT (e), and fused 
FDG-PET/CT (f) demonstrated similar findings (arrows). No patho-
logic FDG-avid foci were detected elsewhere. Based on the labora-
tory and FDG-PET/CT findings, splenic cyst infection was strongly 
considered, although other conditions (in particular malignancy) 
could not be excluded. MRI was ordered for further assessment of 
the spleen. Coronal T2-weighted (g) and gadolinium-enhanced fat-
suppressed T1-weighted (h) images showed a markedly enlarged and 
inhomogeneous spleen (arrows) with cyst-like changes, and centrally 
both T2 hypointense and hyperintense non-enhancing components. 
The differential diagnosis based on the MRI examination included 
hemangioma with hemorrhage, infected splenic cyst with abscess for-
mation, and angiosarcoma. Splenectomy was performed 1 day later, 
which demonstrated angiosarcoma with central hemorrhagic areas
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signs of cyst infection on the FDG-PET/CT scan were con-
sidered as false positives. Patients who met all five criteria 
but did not show signs of infection on the FDG-PET/CT 
scan, were considered as false negatives. The possibility 
that at least some patients were suffering from a cyst infec-
tion without showing all clinical criteria from Sallée et al. 
seems plausible [16].
In conclusion, FDG-PET/CT is a potential imaging 
modality to diagnose cyst infections in ADPKD. However, 
due to the lack of a solid reference standard, most studies 
in this field relied on a combination of clinical factors to 
diagnose cyst infection, which is which is a far from opti-
mal method to validate a new diagnostic tool to validate a 
new diagnostic tool.
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